Home> Products> postpartum hemorrhage

{ "products": [ { "_id": "6979ab153e3091701b89e481", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Misoprostol Tablet 200 mcg", "description": "MISOPIRATE 200 is a pharmaceutical preparation containing Misoprostol 200 mcg, a synthetic prostaglandin E1 analogue that has revolutionized women's healthcare and gastrointestinal treatment protocols. This medication represents a critical therapeutic option in modern medicine, offering solutions for conditions ranging from gastric ulcer prevention to obstetric and gynecological applications. Each tablet of MISOPIRATE 200 is precisely formulated to deliver consistent therapeutic benefits while maintaining strict quality standards.Misoprostol, the active ingredient in MISOPIRATE 200, was initially developed for protecting the gastric lining but has since become indispensable in reproductive healthcare. The medication works by mimicking natural prostaglandins in the body, which are hormone-like substances that regulate various physiological processes including gastric acid secretion, cervical ripening, and uterine contractions.Mechanism of ActionMISOPIRATE 200 functions through multiple pathways depending on the clinical indication. In the gastrointestinal system, it reduces gastric acid secretion by directly inhibiting parietal cells in the stomach lining. Simultaneously, it enhances the production of protective mucus and bicarbonate, creating a defensive barrier against acid-induced damage. This dual action makes it exceptionally effective in preventing and treating peptic ulcers, particularly those induced by nonsteroidal anti-inflammatory drugs (NSAIDs).In obstetric and gynecological applications, MISOPIRATE 200 acts on prostaglandin receptors in the uterus and cervix. It causes the cervix to soften and dilate while stimulating rhythmic uterine contractions. These properties make it valuable for medical management of early pregnancy complications, labor induction, and postpartum hemorrhage prevention.Clinical Uses and ApplicationsGastric Protection: MISOPIRATE 200 serves as a prophylactic agent for individuals requiring long-term NSAID therapy who are at elevated risk for developing gastric or duodenal ulcers. Patients with rheumatoid arthritis, osteoarthritis, or chronic pain conditions who depend on NSAIDs benefit significantly from concurrent misoprostol therapy.Peptic Ulcer Treatment: The medication accelerates healing of existing gastric ulcers by reducing acid exposure and promoting mucosal regeneration. Treatment typically spans four to eight weeks, depending on ulcer severity and individual response.Medical Management of Early Pregnancy Loss: Under strict medical supervision, MISOPIRATE 200 is utilized for managing incomplete miscarriage or missed abortion, offering a non-surgical alternative that many women prefer for emotional and practical reasons.Labor Induction: In hospital settings, healthcare providers may use MISOPIRATE 200 to ripen the cervix and initiate labor when medically indicated, such as in cases of post-term pregnancy or maternal health concerns.Postpartum Hemorrhage Prevention: The medication's ability to promote uterine contractions makes it valuable in preventing excessive bleeding after childbirth, particularly in resource-limited settings.Key Benefits of MISOPIRATE 200Effective Gastric Protection: MISOPIRATE 200 provides superior protection against NSAID-induced gastric damage compared to many alternatives. Clinical studies demonstrate up to 80% reduction in serious gastrointestinal complications among high-risk patients using preventive misoprostol therapy.Non-Invasive Medical Option: For women facing early pregnancy complications, MISOPIRATE 200 offers a medical alternative to surgical procedures, preserving privacy, reducing healthcare costs, and eliminating surgical risks such as anesthesia complications or uterine perforation.Rapid Onset of Action: The medication demonstrates quick absorption and onset, with effects typically beginning within 30 minutes to two hours, allowing for predictable therapeutic outcomes.Cost-Effectiveness: Compared to surgical interventions or hospitalization for complications, MISOPIRATE 200 represents an economical treatment option, making essential healthcare more accessible to diverse populations.Versatile Clinical Applications: The medication's multiple therapeutic uses make it a valuable tool across different medical specialties, from gastroenterology to obstetrics.Stable Formulation: MISOPIRATE 200 maintains stability across various storage conditions, improving accessibility in regions with limited refrigeration infrastructure.Potential Side Effects and Adverse ReactionsWhile MISOPIRATE 200 is generally well-tolerated, users should be aware of possible side effects:Gastrointestinal Disturbances: Diarrhea occurs in approximately 15-40% of patients, typically mild and self-limiting. Abdominal cramping, nausea, and flatulence are also common, particularly during initial treatment phases.Uterine Effects: Women of reproductive age may experience menstrual irregularities, heavier menstrual flow, or intermenstrual spotting. Uterine cramping is expected when the medication is used for obstetric purposes.Vascular Symptoms: Some patients report headaches, dizziness, or hot flashes, though these are generally transient and mild in nature.Allergic Reactions: Though rare, hypersensitivity reactions including skin rashes, itching, or more serious anaphylactic responses can occur and require immediate medical attention.Serious Complications: When used inappropriately for pregnancy termination outside medical supervision, serious complications including incomplete abortion, severe bleeding, infection, or rupture can occur. This underscores the critical importance of medical oversight.Important Precautions and ContraindicationsMISOPIRATE 200 is absolutely contraindicated during pregnancy when the intention is to continue the pregnancy, as it can cause miscarriage or severe fetal abnormalities. Women of childbearing potential must use reliable contraception during treatment. The medication should not be used by individuals with known allergy to prostaglandins or those with inflammatory bowel disease without careful medical evaluation.Patients with cardiovascular disease, cerebrovascular conditions, or poorly controlled hypertension require careful monitoring when using MISOPIRATE 200. The medication may interact with antacids containing magnesium, potentially exacerbating diarrhea.Dosage and Administration GuidelinesDosing of MISOPIRATE 200 varies significantly based on the clinical indication. For gastric protection, typical regimens involve 200 mcg taken two to four times daily with meals. For obstetric uses, dosing protocols are highly specific and must be determined by qualified healthcare providers based on individual circumstances, gestational age, and medical history.The medication should be taken with food to minimize gastrointestinal side effects. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed otherwise by a healthcare provider.ConclusionMISOPIRATE 200 represents a significant therapeutic advancement in both gastroenterology and reproductive healthcare. Its dual capacity to protect the gastric mucosa and influence uterine function makes it an invaluable medication across multiple clinical scenarios. The proven efficacy in preventing NSAID-induced ulcers has prevented countless cases of serious gastrointestinal bleeding, while its role in women's healthcare has expanded access to safe, effective medical management options.", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2287, "imageuri": "https://productimages.withfloats.com/actual/6979ab1bad683d72f6cf0b98.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979ab1bad683d72f6cf0b98.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:22:13.304Z", "updatedon": "2026-03-14T07:17:15.436Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/misoprostol-tablet-200-mcg/2287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MISOPIRATE 200", "category": "GYANECOLOGYRANGE", "tags": [ "misoprostol tablet 200 mcg uses", "misoprostol 200 mcg tablet dosage", "misoprostol 200 mcg tablet benefits", "misoprostol tablet 200 mcg composition", "misoprostol 200 mcg tablet how it works", "misoprostol tablet 200 mcg side effects", "misoprostol 200 mcg tablet mechanism of action", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet storage instructions", "misoprostol 200 mcg tablet for gastric protection", "misoprostol 200 mcg tablet prostaglandin analog", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet administration guide", "misoprostol tablet 200 mcg patient information" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696dda0f911df6d4b0db21c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eltrombopag Olamine Tablets 25 mg", "description": "LTROLAMINE 25 is a prescription medicine containing Eltrombopag Olamine Tablets 25 mg, developed to support patients suffering from low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and a reduced platelet count can significantly increase the risk of bleeding and related complications. LTROLAMINE 25 works by stimulating platelet production in the bone marrow, thereby helping the body maintain a healthier platelet level and reducing bleeding risks.\n\nEltrombopag Olamine is widely used in hematology and liver-related disorders where platelet deficiency is a major concern. LTROLAMINE 25 is formulated with precision to ensure effectiveness, safety, and consistent therapeutic outcomes when used under medical supervision.\n\nWhat is Eltrombopag Olamine Tablets 25 mg?\n\nEltrombopag Olamine is an oral thrombopoietin receptor agonist. It mimics the action of thrombopoietin, a natural hormone responsible for regulating platelet production. By activating thrombopoietin receptors on bone marrow cells, Eltrombopag increases platelet formation and release into the bloodstream.\n\nLTROLAMINE 25 is available in tablet form, making it convenient for long-term management of chronic platelet disorders.\n\nUses of LTROLAMINE 25\n\nLTROLAMINE 25 is primarily prescribed for conditions associated with low platelet counts, including:\n\nChronic Immune Thrombocytopenia (ITP)\nUsed in adults and children who do not respond adequately to corticosteroids, immunoglobulins, or splenectomy.\n\nAplastic Anemia\nHelps stimulate platelet production in patients with severe aplastic anemia who have not responded to immunosuppressive therapy.\n\nHepatitis C–Related Thrombocytopenia\nSupports patients with chronic hepatitis C by improving platelet count, enabling them to receive antiviral therapy safely.\n\nBone Marrow Disorders\nAssists in managing thrombocytopenia caused by bone marrow suppression or dysfunction.\n\nHow LTROLAMINE 25 Works\n\nEltrombopag Olamine works by binding to thrombopoietin receptors (TPO receptors) found on bone marrow precursor cells. Once activated, these receptors stimulate the growth and differentiation of megakaryocytes, which are responsible for producing platelets.\n\nMechanism of Action\n\nActivates thrombopoietin receptors\n\nIncreases megakaryocyte proliferation\n\nEnhances platelet production\n\nImproves circulating platelet count\n\nReduces bleeding risk\n\nUnlike platelet transfusions, LTROLAMINE 25 supports the body’s natural platelet production process, making it suitable for long-term therapy.\n\nKey Benefits of LTROLAMINE 25\n\nEffectively Raises Platelet Count\nHelps maintain platelet levels within a safer range, reducing the need for frequent transfusions.\n\nOral Administration\nTablet form ensures ease of use and better patient compliance.\n\nLong-Term Management\nSuitable for chronic conditions like ITP and aplastic anemia.\n\nReduces Bleeding Risk\nLower chances of spontaneous bleeding, bruising, or internal hemorrhage.\n\nImproves Quality of Life\nPatients experience greater confidence in daily activities with reduced bleeding concerns.\n\nClinically Proven Molecule\nEltrombopag is supported by extensive clinical research in hematological disorders.\n\nDosage and Administration\n\nThe dosage of LTROLAMINE 25 is decided by the treating physician based on:\n\nPatient’s age and weight\n\nPlatelet count\n\nUnderlying medical condition\n\nLiver function status\n\nGeneral Guidelines\n\nTaken once daily on an empty stomach\n\nShould be taken at least 2 hours before or 4 hours after dairy products, calcium, iron, or mineral supplements\n\nDose adjustments are done based on platelet response\n\n⚠️ Always follow the doctor’s prescription and do not self-adjust the dose.\n\nPossible Side Effects of LTROLAMINE 25\n\nLike all medicines, LTROLAMINE 25 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHeadache\n\nNausea\n\nFatigue\n\nDiarrhea\n\nMuscle or joint pain\n\nUpper respiratory tract infections\n\nLess Common but Serious Side Effects\n\nIncreased liver enzymes\n\nBlood clots (if platelet count rises excessively)\n\nCataract formation (with long-term use)\n\nLiver function abnormalities\n\nPatients are advised to undergo regular blood tests to monitor platelet levels and liver function while on LTROLAMINE 25.\n\nPrecautions & Warnings\n\nNot recommended without medical supervision\n\nCaution in patients with liver disease\n\nRegular monitoring of platelet count is essential\n\nShould not be used during pregnancy unless clearly advised\n\nAvoid sudden discontinuation, as platelet count may drop rapidly\n\nInform your doctor about all other medications you are taking to prevent interactions.\n\nStorage Instructions\n\nStore below 30°C\n\nKeep away from moisture and direct sunlight\n\nKeep out of reach of children\n\nConclusion\n\nLTROLAMINE 25 (Eltrombopag Olamine Tablets 25 mg) is a reliable and effective treatment option for patients suffering from thrombocytopenia due to various medical conditions. By stimulating natural platelet production, it reduces bleeding risk, improves treatment outcomes, and enhances overall quality of life. Its oral formulation, proven efficacy, and role in long-term platelet management make LTROLAMINE 25 a valuable medicine in modern hematology care.", "price": 840.0, "discountamount": 252.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2278, "imageuri": "https://productimages.withfloats.com/actual/696dda15ff3886a07028ae89.png", "tileimageuri": "https://productimages.withfloats.com/tile/696dda15ff3886a07028ae89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T07:15:27.702Z", "updatedon": "2026-04-06T07:18:55.865Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//eltrombopag-olamine-tablets-25-mg/2278", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LTROLAMINE 25", "category": "GENERAL RANGE", "tags": [ "eltrombopag 25 mg tablet supplier india", "eltrombopag olamine tablets wholesale price", "eltrombopag 25 mg tablet buy online india", "eltrombopag olamine tablets 50 mg price", "eltrombopag olamine tablets 50 mg", "eltrombopag olamine tablets", "eltrombopag olamine tablets price in india", "eltrombopag olamine tablets price", "eltrombopag 25 mg uses", "eltrombopag 25 mg brands in india", "eltrombopag 25 mg tablet supplier india", "eltrombopag 25 mg wholesale price india", "eltrombopag 25 mg bulk purchase india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695b65af2800555f6696a6cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinacalcet 60 mg Tablet", "description": "CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets\nProduct Overview\nCINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body.\nThe 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet.\nUnderstanding How CINASELECT 60 Works\nCINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream.\nWhen you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH).\nBy lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders.\nPrimary Therapeutic Uses\nSecondary Hyperparathyroidism in Chronic Kidney Disease\nThe primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk.\nCINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues.\nHypercalcemia in Parathyroid Carcinoma\nCINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms.\nPrimary Hyperparathyroidism\nFor patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications.\nKey Benefits of CINASELECT 60\nEffective PTH Control\nClinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification.\nImproved Calcium-Phosphorus Balance\nBy reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life.\nReduced Cardiovascular Risk\nElevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients.\nBone Health Preservation\nUncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density.\nAlternative to Surgery\nFor patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky.\nQuality of Life Improvement\nBy controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity.\nConvenient Oral Administration\nCINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients.\nPotential Side Effects and Adverse Reactions\nCommon Side Effects\nPatients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication.\nDiarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue).\nSerious Side Effects Requiring Medical Attention\nHypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities.\nGastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk.\nAdynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels.\nCardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease.\nAllergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported.\nPrecautions and Contraindications\nCINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH.\nPregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment.\nDosage and Administration Guidelines\nCINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided.\nThe typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved.\nDose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response.\nMonitoring Requirements\nPatients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy.\nAdditionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation.\nStorage and Handling\nCINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package.\nConclusion\nCINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications.\nThe benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management.\nHowever, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2266, "imageuri": "https://productimages.withfloats.com/actual/695b65ebf30763183f64d4f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695b65ebf30763183f64d4f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T07:18:07.264Z", "updatedon": "2026-05-01T06:30:26.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinacalcet-60-mg-tablet/2266", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CINASELECT 60", "category": "NEPHROLOGYRANGE", "tags": [ "cinacalcet 60 mg", "cinacalcet mechanism of action.", "cinacalcet uses", "tab cinacalcet.", "cinacalcet dose.", "cinacalcet structure.", "cinacalcet tab.", "calcium and phosphorus levels in the bloodstream.", "parathyroid hormone secretion.", "calcium metabolism disorders.", "chronic kidney disease and parathyroid conditions.", "cinacalcet 60 mg", "cinacalcet 60", "Cinacalcet Tablets 60 mg price in India", "Buy Cinacalcet Tablets 60 mg online", "Cinacalcet 60 mg wholesale price", "Buy Cinacalcet Tablets 60 mg", "Get Cinacalcet Tablets 60 mg at best price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958dbfa1063d98b1e8f2fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benidipine 4mg", "description": "BENIPRIME 4, containing Benidipine 4 mg, offers effective management for high blood pressure and related heart conditions. This calcium channel blocker helps relax blood vessels to improve blood flow and reduce strain on the heart. Patients often find it reliable for daily control of hypertension symptoms.\n\nWhat is BENIPRIME 4?\nBENIPRIME 4 is a branded tablet from Steris Healthcare Pvt Ltd, featuring 4 mg of Benidipine as the active ingredient. Benidipine belongs to the dihydropyridine class of calcium channel blockers, designed specifically for cardiovascular health. Each tablet delivers a precise dose in a user-friendly form, typically packaged in strips of 10 for convenient use. Manufactured under strict quality standards, it targets essential needs in hypertension care, making it a staple in many treatment plans across India.\n​\n\nThis medication stands out due to its triple action on L-type, N-type, and T-type calcium channels, providing broader vascular protection compared to some other blockers. Doctors prescribe it for adults dealing with persistent high blood pressure or chest pain, often starting at this 4 mg strength for balanced efficacy. Unlike generic options, BENIPRIME 4 ensures consistent absorption and formulation tailored for Indian patients, with pricing around Rs 62-89 per strip after discounts.\n​\n\nHow BENIPRIME 4 Works\nBenidipine in BENIPRIME 4 blocks calcium entry into smooth muscle cells of blood vessels and heart muscles. This action causes vasodilation, widening arteries to lower resistance and ease blood flow. By reducing systolic and diastolic pressure, it lightens the heart's workload without drastically slowing the heartbeat.\n​\n\nThe unique blockade of multiple calcium channels also boosts nitric oxide production, offering antioxidant effects and protection against artery hardening. This sustained mechanism provides 24-hour control, ideal for once-daily dosing after breakfast. Over time, it may even reduce urinary protein and triglycerides, supporting kidney and metabolic health in hypertensives.\n​\n\nKey Uses of BENIPRIME 4\nBENIPRIME 4 primarily treats essential hypertension, helping prevent strokes, heart attacks, and kidney damage. It effectively manages angina pectoris by enhancing coronary blood supply, reducing chest pain episodes during activity.\n​\n\nPhysicians also use it for renal parenchymal hypertension, where kidney issues elevate blood pressure. In emergencies like hypertensive crises or subarachnoid hemorrhage, higher doses prove beneficial, though 4mg serves as maintenance. For arrhythmia or anal fissures linked to vascular strain, it offers supportive relief.\n​\n\nLowers high blood pressure in adults, including severe cases with dose adjustments.\n​\n\nEases angina symptoms, improving exercise tolerance and daily life quality.\n​\n\nProtects renal function in proteinuric patients by stabilizing vessels.\n​\n\nDosage and Administration\nTake BENIPRIME 4 as 4 mg once daily, swallowed whole after a meal to minimize stomach upset. Doctors may adjust to 2-8mg based on response, age, or kidney/liver status, never exceeding 8 mg daily without monitoring. Consistency in timing ensures steady levels for optimal pressure control.\n​\n\nMissed doses require prompt intake if remembered soon, but skip if near the next one—avoid doubles. Pair with lifestyle changes like low-salt diets and exercise for best results. Always consult for personalization, especially in elderly or comorbid patients.\n​\n\nKey Benefits\nBENIPRIME 4 excels in long-term blood pressure reduction, with studies showing sustained drops in brachial-ankle pulse wave velocity beyond mere pressure effects. It protects the heart and kidneys through anti-sclerotic and antioxidant actions, lowering cardiovascular event risks.\n​\n\nPatients experience fewer angina attacks, better endurance, and improved quality of life. The once-daily regimen boosts adherence, while vascular selectivity minimizes reflex tachycardia common in other blockers. Clinical data indicate reduced C-reactive protein and aldosterone, curbing inflammation and fibrosis.\n​\n\nBenefit\tDescription\tSupporting Evidence\nBP Control\tReduces systolic/diastolic pressure effectively over 24 hours \n​\tLong-term studies show persistent effects post-treatment \n​\nHeart Protection\tImproves coronary flow, cuts angina frequency \n​\tMyocardial protection via NO stimulation \n​\nRenal Support\tLowers proteinuria, aids kidney hypertension \n​\tAnti-oxidative vascular benefits \n​\nAdherence Ease\tOnce-daily dosing with sustained release \n​\tHigh membrane affinity for lasting action \n​\nAdditional perks include potential triglyceride reduction and osteoblast stimulation for bone health in hypertensives.\n\nPotential Side Effects\nMost users tolerate BENIPRIME 4 well, with mild, transient effects resolving spontaneously. Common issues include headache, dizziness, flushing, ankle swelling, palpitations, fatigue, nausea, and sleepiness.\n​\n\nLess frequent are constipation, abdominal pain, tinnitus, shoulder stiffness, urinary frequency, or elevated liver enzymes. Rare serious reactions involve severe hypotension, rash, itching, or allergic responses—seek immediate care if these arise. Monitor blood pressure during initiation to avoid drops.\n\nHeart-related: Palpitations, chest pressure\n​\n\nNervous system: Dizziness, headache\n\nSkin/Vascular: Flushing, edema.\n\nGI: Nausea, constipation\n​\n\nLiver/kidney patients need caution; inform doctors of history.\n\n\nPrecautions and Interactions\nAvoid in hypotension, severe aortic stenosis, or hypersensitivity to dihydropyridines. Use cautiously in liver/kidney impairment, pregnancy, or breastfeeding—benefits must outweigh risks. Grapefruit juice may amplify effects; limit alcohol.\n​\n\nIt interacts with beta-blockers, digoxin, or CYP3A4 inhibitors like ketoconazole, potentially enhancing hypotension. Regular monitoring of BP, electrolytes, and renal function is advised during therapy. Abrupt stop may rebound pressure; taper under guidance.\n​\nConclusion\nBENIPRIME 4 with Benidipine 4 mg empowers reliable hypertension and angina control through innovative calcium channel action. Balancing potent benefits like organ protection and ease of use against manageable side effects, it fits seamlessly into modern cardiac care. Consult healthcare providers for tailored integration with lifestyle for lasting heart health. ", "price": 89.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2261, "imageuri": "https://productimages.withfloats.com/actual/6958dbfc615a7d157715572f.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6958dbfc615a7d157715572f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T09:06:02.841Z", "updatedon": "2026-03-13T06:54:02.808Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benidipine-4mg/2261", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENIPRIME 4", "category": "CARDIOLOGYRANGE", "tags": [ "benidipine 4mg", "benidipine 4mg tab", "benidipine hydrochloride uses.", "benidipine.", "benidipine 4 mg", "benidipine 4", "benidipine maximum dose", "benidipine 4 mg uses.", "benidipine price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02a01f5434d48fca8b8e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bethanechol Chloride 50 mg", "description": "BETHNEVOID 50 contains Bethanechol Chloride 50 mg, a cholinergic agonist (parasympathomimetic) that helps stimulate bladder muscle contractions. By directly activating muscarinic receptors in the bladder, it improves urinary flow and assists patients struggling with urinary retention. This makes it especially useful for individuals experiencing difficulty in passing urine due to conditions like post-surgical recovery, postpartum complications, or certain bladder dysfunctions.\n\nThe action of Bethanechol enhances bladder tone, ensuring more effective emptying of urine and reducing the discomfort associated with incomplete bladder evacuation.\n\nUses of BETHNEVOID 50\n\nUrinary Retention Management – Assists patients who are unable to empty their bladder properly.\n\nPost-Surgical Retention – Restores smooth urination after procedures or anesthesia.\n\nNeurogenic Bladder Disorders – Beneficial for those with weak bladder muscles caused by nerve dysfunction.\n\nEnhanced Bladder Emptying – Reduces urinary stasis and lowers the risk of urinary tract infections (UTIs).\n\nSide Effects of BETHNEVOID 50\n\nLike all medicines, BETHNEVOID 50 may cause certain side effects, ranging from mild to less common but serious reactions.\n\nCommon Side Effects:\n\nAbdominal discomfort or cramps\n\nNausea and vomiting\n\nLoose stools (diarrhea)\n\nExcess salivation or sweating\n\nHeadache\n\nLess Common but Serious Side Effects:\n\nLow blood pressure (hypotension)\n\nDizziness or flushing\n\nBreathing difficulties (especially in asthma patients)\n\nIrregular or fast heartbeat\n\nUrinary urgency or overactivity\n\nSeek immediate medical attention if severe symptoms occur.\n\nPrecautions Before Taking BETHNEVOID 50\n\nNot for Obstructive Conditions – Should not be used if urinary obstruction or bladder stones are present.\n\nAsthma or COPD Patients – May aggravate respiratory issues.\n\nCardiac Concerns – Use with caution in individuals with heart disease, peptic ulcers, or low blood pressure.\nPregnancy & Breastfeeding – Only under medical advice.\nDriving & Alertness – May cause dizziness; avoid driving until the effect is known.\nDrug Interactions with BETHNEVOID 50\nOther Cholinergic Drugs – May intensify cholinergic side effects.\nAnticholinergics (e.g., Atropine, Hyoscyamine) – Can reduce Bethanechol’s effectiveness.\nBlood Pressure Medications – Risk of further lowering blood pressure.\n\nBronchoconstrictors – Can worsen respiratory problems if taken together.\n\nConclusion\n\nBETHNEVOID 50 (Bethanechol Chloride 50 mg Tablets) is an effective treatment for urinary retention and bladder dysfunction. By improving bladder muscle contractions, it ensures smoother urination, reduces infection risks, and enhances overall quality of life.\n\nWhen used under proper medical guidance, BETHNEVOID 50 is a reliable choice for patients recovering from surgery or dealing with neurogenic bladder conditions.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2168, "imageuri": "https://productimages.withfloats.com/actual/68b02a049f24dedaddb226a2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b02a049f24dedaddb226a2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T10:05:53.188Z", "updatedon": "2026-05-23T07:39:48.002Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//bethanechol-chloride-50-mg/2168", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BETHNEVOID 50", "category": "UROLOGYRANGE", "tags": [ "Asthma or COPD Patients", "Bethanechol Chloride 50 mg", "bladder dysfunctions.", "bethanechol chloride 50 mg uses", "bethanechol chloride tablets 50 mg benefits", "bethanechol chloride tablets for urinary retention", "bethanechol chloride 50 mg side effects", "bethanechol chloride tablets uses in hindi", "bethanechol chloride tablets for bladder control", "bethanechol chloride tablets review and uses", "bethanechol chloride 50 mg price in india", "bethanechol chloride tablets b2b supplier", "bethanechol chloride 50 mg tablets for urinary retention treatment", "bethanechol chloride 50 mg tablets benefits and uses in india", "bethanechol chloride 50 mg tablet", "bethanechol chloride 50 mg tablet uses in hindi", "bethanechol chloride 50 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6891b0287b16001ae8bc9da2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "citicoline and piracetam tablets", "description": "CITICOTIME PM is a specialized formulation combining Citicoline 500mg and Piracetam 800mg in tablet form, designed to enhance brain health and cognitive functions. This combination harnesses the synergistic effects of two well-researched nootropic agents—citicoline and piracetam tablets—widely used in neurological therapies. Primarily, this medicine supports nerve cell nourishment, protects neurons from damage, and aids in improving memory, focus, and recovery in brain-related conditions such as stroke. Its unique formulation offers neuroprotection and cognitive enhancement, making it an important therapeutic option in treating stroke and other cognitive impairments.\n\nWhat is CITICOTIME PM?\nCITICOTIME PM contains a combination of two active ingredients: Citicoline 500mg, a neuroprotective compound that promotes brain cell repair and function, and Piracetam 800mg, which enhances neuronal communication and cognitive processes. Together, they work to support brain metabolism, improve blood flow, and strengthen cognitive resilience. This formulation is often prescribed to patients recovering from neurological injuries or those experiencing cognitive decline.\n\nUses of Citicoline and Piracetam Tablets\nTreatment and recovery support in stroke patients to restore brain function\nImprovement of memory, learning ability, and cognitive performance\nManagement of neurological disorders such as dementia and Alzheimer's disease\n\nNeuroprotection against brain cell damage caused by trauma or ischemia\nEnhancement of mental alertness and reduction of cognitive fatigue\nSupport in conditions involving cognitive impairment due to aging or injury\nCiticoline + Piracetam is used in the treatment of stroke. Citicoline + Piracetam is a combination of two medicines: Citicoline and Piracetam. Citicoline is a nerve protecting medicine. It works on the brain by nourishing the nerve cells, protects them from damage and improves their survival.\n\nCiticoline and Piracetam Tablets Dosage\nThe recommended dosage depends on the patient's condition, age, and response to therapy. Typically, CITICOTIME PM is taken once or twice daily as prescribed by a healthcare professional. Each tablet delivers Citicoline 500mg and Piracetam 800mg, providing an effective dose for neuroprotection and cognitive support. It should be swallowed whole with water, preferably after meals to reduce gastrointestinal discomfort. Dosage adjustments may be necessary in patients with kidney impairment or other comorbidities. It is critical to follow a doctor's prescribed dosage and not to self-medicate.\n\nSide Effects of Citicoline and Piracetam Tablets\nWhile generally well tolerated, some individuals may experience side effects, which are usually mild and temporary, including:\nHeadache\nNausea and stomach discomfort\n\nInsomnia or trouble sleeping\nNervousness or agitation\nDizziness and vertigo\n\nWeight gain in some cases\n\nRare allergic reactions such as skin rash or swelling\nChanges in blood pressure or heart rate (typically uncommon)\nIf severe side effects or allergic reactions occur, immediate medical attention is advised.\nPrecautions Before Using CITICOTIME PM\n\nConsult a doctor before use if you have a history of brain hemorrhage, bleeding disorders, or gastrointestinal ulcers.\n\nUse caution in elderly patients and those with renal or hepatic impairment.\n\nAvoid driving or operating heavy machinery until you know how the medicine affects you.\nDo not consume alcohol while taking this medication, as it may increase side effects like drowsiness or nervousness.\nInform your healthcare provider if you are pregnant, trying to conceive, or breastfeeding, as safety in these conditions is not fully established.\n\nDo not abruptly stop the medication without medical advice to avoid withdrawal symptoms such as muscle twitching.\nDrug Interactions: What Drugs Interact with CITICOTIME PM?\nAnticoagulants or blood thinners may increase the risk of bleeding.\nOther central nervous system (CNS) stimulants or depressants can enhance side effects like dizziness or drowsiness.\nMedications processed by kidneys require careful monitoring as both citicoline and piracetam are primarily excreted renally.\nAlcohol consumption can exacerbate side effects, especially sedation and nervousness.\nAlways inform your doctor about all medications and supplements you are taking to avoid harmful interactions.\n\nCITICOTIME PM, with citicoline 500mg and piracetam 800mg, is a reliable choice for managing stroke recovery and cognitive disorders by protecting and nourishing nerve cells, improving brain function, and supporting neuronal survival. Proper medical supervision is essential to maximize benefits and minimize risks associated with citicoline and piracetam tablets uses and dosage.", "price": 495.94, "discountamount": 148.94, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2155, "imageuri": "https://productimages.withfloats.com/actual/6891b02f5058847bfcd48899.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891b02f5058847bfcd48899.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T07:18:00.92Z", "updatedon": "2026-03-12T09:08:25.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//citicoline-and-piracetam-tablets/2155", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CITICOTIME PM", "category": "NEUROLOGY RANGE", "tags": [ "citicoline and piracetam tablets", "citicoline 500mg", "piracetam 800mg", "nerve cells", "citicoline and piracetam tablets", "promotes brain cell" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2026-03-14T06:46:45.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer", "nintedanib 100 mg", "nintedanib capsules 100 mg", "nintedanib 100 mg capsules", "nintedanib 100 mg medicine", "nintedanib 100 mg tablet uses", "what is nintedanib 100 mg used for", "how nintedanib 100 mg works", "nintedanib 100 mg uses and benefits", "nintedanib 100 mg for lung disease", "nintedanib 100 mg for pulmonary fibrosis", "nintedanib 100 mg for idiopathic pulmonary fibrosis", "nintedanib 100 mg for interstitial lung disease", "nintedanib capsules for chronic lung disease", "nintedanib 100 mg price in india", "nintedanib 100 mg capsules price", "buy nintedanib 100 mg online", "nintedanib 100 mg supplier india", "nintedanib 100 mg manufacturer", "when should nintedanib 100 mg be taken", "who should take nintedanib 100 mg", "can nintedanib slow lung fibrosis", "how long to take nintedanib 100 mg", "does nintedanib cure pulmonary fibrosis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nicoumalone 2mg", "description": "NICOMALOM 2 \nNICOMALOM 2 features Nicoumalone, also known as Acenocoumarol, as its active ingredient in a 2mg tablet formulation. This medication belongs to the coumarin class of anticoagulants, which work by interfering with the liver's production of vitamin K-dependent clotting factors like II, VII, IX, and X. Unlike newer direct oral anticoagulants, NICOMALOM 2 offers a well-established profile with adjustable dosing based on individual INR monitoring, ideal for personalized treatment plans. Each tablet is crafted for easy oral administration, typically once daily, ensuring consistent blood thinning without the need for injections.\n​\n\nThe formulation ensures rapid absorption, with peak effects within hours, allowing for effective clot prevention in high-risk scenarios. Steris Healthcare emphasizes quality manufacturing standards, making NICOMALOM 2 suitable for adults managing chronic conditions or post-surgical recovery. Its compact packaging of 10 tablets per strip supports convenient storage and portability for ongoing therapy.\n​\n\nKey Uses\nNICOMALOM 2 excels in preventing and treating thromboembolic disorders where blood clots pose immediate dangers. Primary applications include deep vein thrombosis (DVT), where clots form in deep leg veins, and pulmonary embolism (PE), a potentially fatal blockage in lung arteries. Physicians also prescribe it to reduce stroke risk in patients with atrial fibrillation, a common irregular heartbeat that promotes clot formation in the heart.\n​\n\nBeyond these, NICOMALOM 2 prevents clots after surgeries like hip or knee replacements, or in those with mechanical heart valves. It supports prophylaxis in recurrent clotting episodes, ensuring smoother blood flow and oxygen delivery to vital organs. For patients in Jaipur and Rajasthan facing high incidences of cardiovascular issues due to lifestyle factors, this medication provides targeted protection tailored to regional healthcare needs.\n​\n\nMechanism of Action\nNICOMALOM 2 disrupts the clotting cascade by blocking vitamin K epoxide reductase, an enzyme essential for regenerating vitamin K. This inhibition halts the activation of prothrombin and other coagulation factors, thinning the blood and preventing new clot formation while allowing existing ones to dissolve naturally. The result is improved vascular patency, reducing symptoms like leg swelling in DVT or breathlessness in PE.\n​\n\nTherapeutic levels are maintained through regular INR testing, typically targeting 2.0-3.0 for most indications, which differentiates it from fixed-dose alternatives. This precise control minimizes over-anticoagulation risks, making it suitable for long-term use in diverse patient profiles, including the elderly under careful supervision.\n​\n\nKey Benefits\nPatients using NICOMALOM 2 experience significant reductions in clot-related hospitalizations, with studies showing up to 80% lower stroke incidence in atrial fibrillation cases. Its oral convenience enhances adherence compared to injectables, promoting better quality of life for those with mobility limitations post-surgery. Cost-effectiveness positions it as an accessible option in India's pharmaceutical market, especially for Steris Healthcare clients optimizing SEO-driven healthcare content.\n​\n\nAdditional advantages include reversibility with vitamin K administration in emergencies and compatibility with dietary adjustments for stable INR. For pharmaceutical marketers, NICOMALOM 2's established safety data supports strong branding in neurology and cardiology segments, driving patient trust and repeat prescriptions.\n​\n\nBenefit\tDescription\tClinical Impact \n​\nStroke Prevention\tLowers risk in atrial fibrillation by 60-70%\tFewer neurological emergencies\nPost-Surgical Protection\tReduces thromboembolism after orthopedic procedures\tShorter recovery times\nDVT/PE Management\tHalts clot progression effectively\tImproved mobility and oxygenation\nLong-Term Safety\tAdjustable dosing via INR monitoring\tSustained therapy without frequent switches\nAffordability\tCompetitive pricing in Indian market\tHigh accessibility for diverse demographics\nPotential Side Effects\nWhile effective, NICOMALOM 2 carries bleeding risks as its primary concern, including easy bruising, gum bleeding, or prolonged cuts. Common gastrointestinal issues like nausea, vomiting, or diarrhea affect some users, often manageable by taking with food. Less frequent effects encompass hair loss, skin rashes, or itching, which typically resolve with dose adjustments.\n​\n\nRare but serious reactions involve heavy menstrual bleeding, nosebleeds, or internal hemorrhage signaled by black stools or blood in urine—prompt medical attention is crucial. Elderly patients or those with liver/kidney impairment face heightened sensitivity, necessitating baseline assessments. Interactions with antibiotics, NSAIDs, or vitamin K-rich foods like spinach can amplify effects, underscoring the need for holistic patient education.\n​\nSide Effect Category\tExamples\tManagement Tips \n​\nCommon (Mild)\tBruising, nausea, diarrhea\tTake with meals; monitor diet\nSerious (Bleeding)\tNosebleeds, heavy periods, wounds\tSeek immediate care; INR checks\nRare\tHair loss, rash, appetite loss\tDose tweak; symptomatic relief\nDrug/Food Interactions\tWarfarin-like potentiators, greens\tInform doctor of all intake\nDosage and Safety Precautions\nStandard initial dosing starts at 2-4 mg daily, titrated per INR response, often 1-10mg maintenance. Children and the elderly require caution with lower starts. Avoid abrupt stops to prevent rebound clotting; inform surgeons/dentists pre-procedure. Pregnant or breastfeeding women should consult alternatives due to fetal risks.\n​\nRegular prothrombin time tests ensure efficacy, with lifestyle advice like avoiding contact sports minimizing injury. Store at room temperature, away from moisture.\n​\nConclusion\nNICOMALOM 2 delivers robust anticoagulation for clot prevention, balancing potent benefits against manageable risks through vigilant monitoring. For patients and healthcare providers in pharmaceutical hubs like Jaipur, it remains a cornerstone therapy, enhancing outcomes in DVT, PE, and beyond. Always prioritize professional guidance for optimal results.", "price": 227.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2026-03-13T05:57:23.788Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicoumalone-2mg/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }